Etiologic Heterogeneity of Hyperapobetalipoproteinemia (HyperapoB)
- 1 November 1997
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 17 (11) , 2729-2736
- https://doi.org/10.1161/01.atv.17.11.2729
Abstract
Abstract Hyperapobetalipoproteinemia (hyperapoB) is a common familial lipoprotein disorder associated with premature coronary artery disease (CAD). HyperapoB is characterized by an increased number of small, dense LDL particles. Patients with hyperapoB may be normotriglyceridemic (normoTG) or hypertriglyceridemic (hyperTG). We tested the hypothesis that a major locus controls the hyperapoB phenotype by using data from 1035 participants in 145 families enriched for premature CAD. Segregation analysis was conducted, and results suggest etiologic heterogeneity in these families. Families (n=55) with one or more hyperTG hyperapoB individuals strongly supported mendelian recessive inheritance of hyperapoB. Under this mendelian model, individuals with the high-risk genotype had a baseline risk of 0.78, but parental and spouse’s hyperapoB phenotypes did influence the probability of displaying hyperapoB. Low-risk genotypes had virtually no risk of displaying hyperapoB. The other subgroup of families (n=72), in which all hyperapoB individuals were normoTG, did not show any clear pattern of inheritance. Eighteen families did not have any hyperapoB individual. In the 55 families with hyperTG hyperapoB, diabetes was more prevalent in hyperapoB individuals (18.3% of hyperTG hyperapoB individuals, 9.6% of normoTG hyperapoB individuals) than in normal individuals (4.9%). Both hyperTG hyperapoB and normoTG hyperapoB phenotypes were significant predictors for blood pressure in the 55 families, but not in the total population. These associations further suggest a link between hyperapoB and the small, dense LDL syndromes. This study successfully demonstrated mendelian inheritance of the hyperapoB phenotype and also suggested etiologic heterogeneity of hyperapoB.Keywords
This publication has 17 references indexed in Scilit:
- Genetics and molecular biology of familial combined hyperlipidemiaCurrent Opinion in Lipidology, 1993
- Prevalence of hyperapobetalipoproteinemia and other lipoprotein phenotypes in men (aged ≤50 years) and women (≤60 years) with coronary artery diseaseThe American Journal of Cardiology, 1993
- Segregation Analysis of Esophageal Cancer in 221 High-Risk Chinese FamiliesJNCI Journal of the National Cancer Institute, 1992
- Apolipoprotein, low density lipoprotein subfraction, and insulin associations with familial combined hyperlipidemia. Study of Utah patients with familial dyslipidemic hypertension.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1989
- Role of Insulin Resistance in Human DiseaseDiabetes, 1988
- GENETIC CONTROL OF LOW-DENSITY-LIPOPROTEIN SUBCLASSESThe Lancet, 1986
- Familial aggregation and early expression of hyperapobetalipoproteinemiaThe American Journal of Cardiology, 1985
- The Relation of Risk Factors to the Development of Atherosclerosis in Saphenous-Vein Bypass Grafts and the Progression of Disease in the Native CirculationNew England Journal of Medicine, 1984
- Probability functions on complex pedigreesAdvances in Applied Probability, 1978
- Hyperlipidemia in Coronary Heart Disease II. GENETIC ANALYSIS OF LIPID LEVELS IN 176 FAMILIES AND DELINEATION OF A NEW INHERITED DISORDER, COMBINED HYPERLIPIDEMIAJournal of Clinical Investigation, 1973